作者: Philip A. Roberts , Younes Boudjemline , John P. Cheatham , Andreas Eicken , Peter Ewert
DOI: 10.1016/J.JACC.2011.01.044
关键词: Ventricle 、 Heart disease 、 Surgery 、 Percutaneous 、 Stenosis 、 Cardiology 、 Regurgitation (circulation) 、 Medicine 、 Tricuspid valve 、 Tricuspid valve replacement 、 Internal medicine 、 Pulmonary valve
摘要: Objectives This study sought to describe the first human series of percutaneous tricuspid valve replacements in patients with congenital or acquired (TV) disease. Background Percutaneous transcatheter heart replacement ventriculoarterial (aortic, pulmonary) valves is established. Although there are isolated reports atrioventricular (hybrid and percutaneous), this procedure has been less frequently described; we aware no describing for TV Methods We approached institutions significant experience Melody pulmonary (Medtronic, Inc., Minneapolis, Minnesota) collect data where had implanted position. Clinical procedural were gathered 15 patients. Indications intervention included severe hemodynamic compromise perceived high surgical risk; all prior surgery stenosis and/or regurgitation a bioprosthetic right atrium–to–right ventricle conduit. Results Procedural success was achieved In predominantly stenosis, mean gradient reduced from 12.9 3.9 mm Hg (p Conclusions selected cases, may be candidates replacement.